Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant

被引:0
作者
Yixuan Wang
Yan Yao
Qingfeng Zhang
Hao Chen
Yang He
Ke Hu
机构
[1] Renmin Hospital of Wuhan University,Department of Respiratory and Critical Care Medicine
[2] Renmin Hospital of Wuhan University,Department of Pharmacy
来源
BMC Infectious Diseases | / 24卷
关键词
COVID-19; CAPA; SARS-CoV-2; Omicron variant; Aspergillosis; NLR; Mortality;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 112 条
[1]  
Goh AXC(2023)Characteristics of the omicron XBB subvariant wave in Singapore Lancet (London England) 401 1261-2
[2]  
Chae SR(2021)State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia Infection 49 591-605
[3]  
Chiew CJ(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet (London England) 395 1054-62
[4]  
Tang N(2021)Late onset infectious complications and safety of tocilizumab in the management of COVID-19 J Med Virol 93 1459-64
[5]  
Pang D(2021)A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit Clin Infect Diseases: Official Publication Infect Dis Soc Am 73 e1634-e44
[6]  
Lin C(2021)Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance Lancet Infect Dis 21 e149-e62
[7]  
Chong WH(2022)Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis Infection 50 43-56
[8]  
Saha BK(2021)COVID-19-Associated pulmonary aspergillosis (CAPA) J Intensive Med 1 71-80
[9]  
Ananthakrishnan R(2021)Risk factors for invasive aspergillosis in patients admitted to the Intensive Care Unit with Coronavirus Disease 2019: a Multicenter Retrospective Study Front Med 8 753659-81
[10]  
Chopra A(1998)Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 2265-206